-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Allegion (ALLE) posted Q1 adjusted EPS of $1.80 vs. $1.86 (-3%), $0.10 short of consensus. Net sales rose 9.7% Y/Y (+2.6% organically) to $1.03B ($10M ahead of consensus). The organic revenue increase was driven by price realizations partially offset by volume declines. The reported revenue increase also reflects a 4.8% net positive impact from acquisitions and divestitures, as well as a 2.3% tailwind from foreign currency. Adjusted operating margin contracted 150 bps to 21.2% due to headwinds from volume declines and price and productivity net of inflation and investment (PPII). During Q1, ALLE repurchased 0.3M shares for $40M and paid dividends of $47M (a quarterly dividend of $0.55 per share). Management maintained prior full year 2026 guidance, including adjusted EPS in the range of $8.70-$8.90. Shares are currently trading 4% lower in pre-market trading on the earnings miss - its second in a row following a streak in which its bottom line had not fallen short of consensus since 2019.